| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00005778043 |
| 005 |
20260407184550.4 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
250505s2025 enk o 001 0 eng d |
| 040 |
|
|
|a UKRSC
|b eng
|e rda
|c UKRSC
|d OCLCO
|d EBLCP
|d UIU
|d UKAHL
|d UKKRT
|d CLOUD
|d N$T
|
| 019 |
|
|
|a 1518039583
|
| 020 |
|
|
|a 9781837676941
|q (electronic bk.)
|
| 020 |
|
|
|a 1837676941
|q (electronic bk.)
|
| 020 |
|
|
|a 183767695X
|
| 020 |
|
|
|a 9781837676958
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)1518432853
|z (OCoLC)1518039583
|
| 037 |
|
|
|a RSC-667a969a0de52
|b Royal Society of Chemistry
|n http://www.rsc.org/spr
|
| 050 |
|
4 |
|a RS420
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI
|x 013040
|2 bisacsh
|
| 072 |
|
7 |
|a MMG
|2 bicssc
|
| 072 |
|
7 |
|a PDND
|2 bicssc
|
| 072 |
|
7 |
|a PNN
|2 bicssc
|
| 072 |
|
7 |
|a PSB
|2 bicssc
|
| 072 |
|
7 |
|a TTBM
|2 bicssc
|
| 082 |
0 |
4 |
|a 615.19
|2 23/eng/20250505
|
| 049 |
|
|
|a TXAM
|
| 245 |
0 |
0 |
|a High content imaging in drug discovery /
|c edited by James Pilling, Neil Carragher.
|
| 264 |
|
1 |
|a Cambridge :
|b Royal Society of Chemistry,
|c 2025
|
| 300 |
|
|
|a 1 online resource (292 pages).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a Drug discovery series ;
|v Volume 86
|
| 505 |
0 |
|
|a Imaging Technology Platforms, State-of-the-art and Future Developments Assay Development and Automation in High Content Screening Beyond Images: Data Extraction, Analysis and Interpretation Morphological Profiling: Case Studies and Applications AI and Chemogenomics in High Content Screening Screen in Haste, Repent at Leisure: Some Advice for Running a High Content Screening Campaign High Content Screening to Identify Interventions Targeting Coronavirus Host Infection and Replication Lead Identification Using 3D Organoid Models of Pancreatic Cancer Imaging on a Macro Scale: Application of Complex and Translational Models Morphological Profiling: Advancing Towards 4D Phenotypic Profiling Deep-learning Enhanced Phenotypic Screening and Cheminformatics for Antibiotic, Antimicrobial and Bioactives Discovery
|
| 520 |
|
|
|a High content imaging is a foundational technology platform in pre-clinical drug discovery, supporting the generation of key decision-making data at most, if not all, points along the journey from target identification to the development of candidate therapeutics. The breadth of available technology and the biology to which it is applied is vast, and recent advances in the ability to generate and interpret huge datasets are a paradigm shift in how this technology can be used on a large scale in early drug discovery. This comprehensive resource covers state-of-the-art technologies, essential supporting infrastructure and data analysis approaches to support pre-clinical drug discovery. Chapters will describe key considerations and recommendations for establishing an assay for high content imaging microscopy platforms, what is required to support the use of such platforms, critical image handling infrastructure, and also how to apply high content imaging. Additionally, case studies and examples will provide a guide to the latest advances in the field, such as cell painting/morphological profiling, the inclusion of complex cellular and more advanced 3-dimensional cell models, and the use of traditionally low throughput techniques to support hit and target discovery. High Content Imaging in Drug Discovery brings together the many advances, challenges, and their solutions into a single essential resource for scientists and leaders working in high content imaging and seeking to establish capability within their drug discovery processes.
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Vendor-supplied metadata.
|
| 650 |
|
0 |
|a Drugs
|x Design
|x Technological innovations.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
|
0 |
|a Imaging systems.
|
| 650 |
|
2 |
|a Technology, Pharmaceutical
|
| 650 |
|
6 |
|a Médicaments
|x Conception
|x Innovations.
|
| 650 |
|
6 |
|a Techniques pharmaceutiques.
|
| 650 |
|
6 |
|a Imagerie (Technique)
|
| 650 |
|
7 |
|a MEDICAL / Pharmacology
|2 bisacsh
|
| 650 |
|
7 |
|a SCIENCE / Chemistry / Organic
|2 bisacsh
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 700 |
1 |
|
|a Pilling, James,
|e editor.
|
| 700 |
1 |
|
|a Carragher, Neil,
|e editor.
|
| 710 |
2 |
|
|a Knovel (Firm)
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://app.knovel.com/hotlink/toc/id:kpHCIDD008/high-content-imaging?kpromoter=marc
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Knovel ebooks
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
f |
f |
|i 7dc91096-93b4-4702-9707-c7a6d3d7169b
|s b0c9dcc2-be14-41a6-9fbf-cd731d1c321c
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e RS420
|h Library of Congress classification
|
| 998 |
f |
f |
|a RS420
|t 0
|l Available Online
|